So I just read this piece about cannabis penny stocks potentially being 3-baggers over the next couple years, and honestly the thesis makes some sense. Germany legalized weed, other European countries are probably following, and the US is talking about rescheduling cannabis to Schedule III. The regulatory tailwinds could actually be real this time.



They're bullish on three weed penny stocks specifically. Cronos (CRON) supposedly has $862 million cash and just entered Germany and Australia - decent position if legalization actually happens. Then there's Tilray (TLRY), which is interesting because they own craft beer brands too, so they've got distribution infrastructure ready to pivot if federal legalization kicks in. Last one is Curaleaf (CURLF), which has been up 83% in the past year but they're saying it's still undervalued and 2024 was supposed to be their catalyst year.

The article makes the point that unlike a few years ago when cannabis companies were bleeding cash, some of these bigger players actually have operating leverage and positive cash flow now. So theoretically if regulations actually improve, these could pop hard. But honestly, we've heard the federal legalization story before. Still, worth watching if you're into penny stocks and have a 2-year horizon. What's your take - is this the year cannabis finally gets serious regulatory movement?
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin